NEFL and Parkinson disease: Indeed, when NF-L levels were measured by electrochemiluminescence immunoassay in sera from patients with PD (>2 years of diagnosis; n = 146), ET (n = 82) and 60 age-matched healthy controls, significantly higher levels were found in PD than in ET and healthy controls.